NEW YORK (GenomeWeb) – Bayer HealthCare today announced it has expanded a drug development collaboration with the Broad Institute to include cardiovascular genomics. 

As part of the expanded deal, Bayer and the Broad will collaborate on genetic discovery, target identification, and drug discovery activities. A joint steering committee and joint research committee will oversee research progress and direction, Bayer said. Financial and other terms of the deal were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.